End-to-end Biologics CDMO
From cell line to commercial fill-finish, we develop and manufacture high-quality biologics that improve lives worldwide.
Explore Capabilities
Shilpa Biologicals is an end-to-end biopharmaceutical company delivering global-quality biologics, affordably — from India to the World.
Independently certified and internationally recognised — our quality systems, regulatory approvals and export credentials are benchmarked for the world's most demanding markets, so every program is built and released to global expectations.
Shilpa Biologicals develops and manufactures complex biologics end-to-end — taking each program from cell line development through drug substance and final fill-finish, all within a single integrated site. Fewer hand-offs mean tighter control, faster timelines, and quality that holds from first vial to last.
By pairing scientific depth with internationally benchmarked quality systems, we make global-standard biologics genuinely accessible — helping partners bring affordable therapies from India to patients around the world.
Share your program and our scientific team will respond at its soonest — whether you need a CDMO partner, biosimilar licensing or recombinant albumin supply.
Trusted by partners across the US · EU · Canada · Brazil · Japan
From cell line to commercial fill-finish, we develop and manufacture high-quality biologics that improve lives worldwide.
Explore Capabilities
Cost-effective biosimilars developed with precision, safety, and global regulatory standards.
Learn More
High-purity, well-characterized rHSA for therapeutic and research applications.
Learn More
Advanced conjugation platforms for next-gen targeted therapies and complex molecules.
Learn More
Our proprietary albumin platform engineered for enhanced stability and drug delivery.
Learn MoreShilpa Biologicals is an integrated biopharmaceutical company in India that develops and manufactures biologics for partners across the United States, Europe, Canada, Brazil and Japan. From a single integrated campus in Dharwad, we combine novel biologics development, biosimilars, antibody-drug conjugates and recombinant human albumin — the full breadth of modern biologics development and manufacturing in India, under internationally benchmarked quality.
As a novel biologics development partner, we bring together scientific depth, end-to-end biopharmaceutical manufacturing and a cost base that makes high-quality biologics more affordable. Whether you are advancing a first molecule or scaling toward commercial supply, Shilpa Biologicals offers a single, accountable home for your program — from cell line through final fill-finish.
From novel biologics and biosimilars to recombinant human albumin, Shilpa Biologicals exists to make high-quality biopharmaceutical products more affordable and more accessible. As an affordable biopharmaceuticals manufacturer and a biosimilars and biologics company, we partner with innovators worldwide to bring the therapies patients depend on within reach — without compromising on the standards the biopharmaceutical industry demands.
Request a QuoteOne accountable partner in Dharwad, India — delivering global-quality biologics to regulated and emerging markets worldwide.
Dharwad, India
India United States Canada United Kingdom
France
Germany
Spain
Italy
Netherlands
Sweden
Belgium
Switzerland
Poland
Portugal
Austria Brazil JapanShilpa Biologicals is a fully integrated biopharmaceutical company in India, focused exclusively on biologics. We develop and manufacture biologics for partners worldwide, bringing novel biologics, biosimilars, antibody drug conjugates and recombinant human albumin together under one organisation and one quality system.
As a biologics company India can rely on, Shilpa Biologicals gives partners one accountable point of contact for a molecule, from its earliest research stage through to commercial supply. This integrated biologics company model removes the friction of coordinating separate vendors for development, manufacturing and testing, so a program moves with one team that understands the full journey of a biologic. Under one roof we bring together:
That continuity is the foundation of how we work and the reason partners treat us as a long term extension of their own teams.
Our working approach centres on genuine end-to-end biologics solutions delivered from one integrated campus in Dharwad. Keeping every stage of biologics manufacturing India under a single quality system shortens technical transfer, protects timelines and removes the risk that appears when a program is split across multiple sites. As a biologics solutions provider, we carry a molecule through the complete value chain:
We scale each program in step with its needs, from early development batches through to larger commercial volumes, holding one consistent thread of quality, data and documentation from the first cell line to the final vial.
Trust in biopharmaceutical manufacturing is earned through quality systems rather than claims. Shilpa Biologicals operates as a WHO-GMP biologics manufacturer with controls benchmarked for the most tightly regulated markets:
Every program is developed and released to meet the expectations of regulators across the United States, Europe, Canada, Brazil and Japan. This commitment to global quality standards, supported by the scientific depth of an experienced team, lets partners place complex biologics programs with us and stay confident in the outcome.
A core part of what Shilpa Biologicals provides is a growing biosimilars portfolio that widens patient access to high cost biologics. As a biosimilars and biologics company, we are developing candidates across oncology, autoimmune and dermatology indications, giving health systems and licensing partners more affordable routes to established therapies. Biosimilars will be available commercially after relevant patent expiry. As an affordable biopharmaceuticals manufacturer, our purpose is to help high quality biopharmaceutical products reach more patients, and affordability here is the result of efficient processes and an optimised cost base, never a compromise on quality, safety or compliance.
Beyond biosimilars, Shilpa Biologicals works as a novel biologics development partner across three further areas:
Bringing these very different molecule types under one quality system is what separates a fully integrated biologics company from a single service vendor, and it gives partners room to grow the relationship as their pipeline evolves.
For partners assessing options across the wider biopharmaceutical industry, an Indian biopharma manufacturer with global standards offers a combination that is hard to find:
The result is a global biologics company with roots in India and real reach across its priority markets. To start a conversation, share your molecule and our scientific team will respond.